Ludwig Cancer Research
Legal name: Licr Fund Inc
Nonprofit profile at a glance
- EIN
- 133573053
- IRS 990 coverage
- 2018–2024
- Official website data refreshed
- Sep 2026
- Forms available
- Form 990 2024, Form 990-T 2024
- Location
- New York, New York, US
- Phone
- (212) 450 1500
- Rating
- 81
- Verdict
- STRONG
- Rating confidence
- Moderate
- Sector
- Single Organization Support
Reported finances
- Revenue
- $79,026,554
- Expenses
- $69,041,808
- Assets
- $1,936,672,464
- Liabilities
- $6,684,481
Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.
Leadership & pay
13 people listed
Executive titles in this filing
- XING CHEN (DIRECTOR, PRESIDENT, CIO)
- AVANTIKA PATEL (VICE PRESIDENT)
Highest reported compensation
- XING CHEN (DIRECTOR, PRESIDENT, CIO): $1,196,997 total reported compensation
- DR CHI VAN DANG (DIRECTOR): $1,180,151 total reported compensation
- EDWARD A MCDERMOTT JR (DIR, BOARD CHAIR (FROM 7/24)): $670,727 total reported compensation
Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
To accelerate cancer research through the management of the endowment for the Ludwig Institute for Cancer Research, supporting Ludwig Centers and professorships at six U.S. institutions.
What it reported doing in 2024
Licr fund, inc. ("the fund") is a non-profit Delaware corporation that holds a diversified portfolio of investments from which it provides annual support to the ludwig institute for cancer research ltd ("the institute"). The institute is exempt under irc section 501(c)(3) and is not a private foundation because it is a medical research organization, described in irc section 170(b)(1)(a)(iii), engaged in medical research into the causes and cure of cancer in conjunction with qualified hospitals. In 2024 the fund provided grants and other assistance directly to the institute in the amount of $61,000,000 to support the institute's medical research activities, including laboratory research and clinical trials.
Operating model
- Revenue model
- Investment-supported. 99% of the money available for current operations came from recurring investment income.
- Distribution model
- Grant intermediary. The nonprofit sent 100% of its reported program spending out as grants.
- Includes noncash contributions: Reported contributions include donated property or goods.
The verdict
STRONG - A large share of available resources goes toward mission work and the filed numbers largely add up. The filing reports few safeguards for money sent abroad and revenue has declined or grown slowly.
Rating breakdown
- Financial Efficiency: 85
- Transparency & Controls: 79
- Accountability: 82
- Sustainability: 85
- Growth: 60
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 100%; rating input score 100
- Program expense ratio: 88.4%; rating input score 88
- Fundraising efficiency: Limited
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 68th percentile among comparable filings
- Pay-setting controls: 5 of 6 controls in place; rating input score 83
- Compensation committee: Pass
- Independent consultant: Pass
- Other Form 990s reviewed: Pass
- Written employment contract: Missing
- Compensation survey or study: Pass
- Board or committee approval: Pass
- Foreign activity oversight: 1 of 8 controls in place; rating input score 12
- Claims monitoring procedures: Pass
- Requires narrative reports: Fail
- Conducts field audits: Fail
- May suspend future funding: Fail
- Requires financial reports: Fail
- Conducts site visits: Fail
- Requires grant agreements: Fail
- May require repayment: Fail
- Grant itemization coverage: 100%; rating input score 100; 77th percentile among comparable filings
- Major donor itemization: Yes; rating input score 100
- Related-party transparency: Limited
Accountability
- Independent voting board: 70%; rating input score 70; 21st percentile among comparable filings
- Governance controls: 9 of 9 controls in place; rating input score 100
- Conflict-of-interest policy: Pass
- Whistleblower policy: Pass
- Document-retention policy: Pass
- CEO compensation review process: Pass
- Other executive compensation review process: Pass
- Form 990 shared with the board: Pass
- Board meeting minutes documented: Pass
- Audit committee oversight: Pass
- Independent financial-statement audit: Pass
Sustainability
- Operating margin: 12.6%; rating input score 78; 78th percentile among comparable filings
- Total-asset coverage ratio: 28.05; rating input score 99; 99th percentile among comparable filings
- Liabilities to assets ratio: 0; rating input score 97; 97th percentile among comparable filings
- Officer compensation ratio: 1.4%; rating input score 68; 68th percentile among comparable filings
Growth
- Program expense growth: 6.7% per year; rating input score 100; 54th percentile among comparable filings
- Revenue growth: -9.5% per year; rating input score 0; 0th percentile among comparable filings
- Asset growth: 3.7% per year; rating input score 100; 26th percentile among comparable filings
Details
- What they do: 2 programs and campaigns described on the official site · 1 operating location identified
- Where the money goes: 100% of revenue deployed · 88.4% of spending went to programs
- Governance: 7 of 10 board members independent · 9 of 9 filing controls reported
- Programs: 1 filed program accomplishment · $61M in reported program spending
- Leadership: top reported pay $1.2M · 13 people listed · 5 of 6 pay-setting controls reported
- Highest-paid contractors: 5 contractors listed · $5.6M reported
- Consistency: 26 of 26 current checks pass
- Schedules: 7 filed schedules · includes major donors, foreign activity, and executive pay
- Filing history: 6 filing years from 2018 to 2024
- Contacts: How to reach this organization
- Money network: 9 filed money-flow records
- Related organizations: 5 filed related-organization links
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Transparency & Controls: Foreign activity oversight: 7 of 8 not reported.
- High — Growth: Revenue growth scored 0/100.